Skip to content

Clinical trials

Completed Carcinoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma Status: Completed Country / region: United States Clear all

205 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20028
200312
20043
200513
200616
20077
200814
200915
201011
20119
201213
20136
20148
20159
20167
201710
20185
20196
20209
20218
20225
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed205

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer11
Novartis Pharmaceuticals10
H. Lee Moffitt Cancer Center and Research Institute7
National Cancer Institute (NCI)7
Eli Lilly and Company6
Akamis Bio5
University of Chicago5
National Institute of Neurological Disorders and Stroke (NINDS)4
Oncolytics Biotech4
Stanford University4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma205
Neoplasms77
Neoplasm Metastasis35
Carcinoma, Non-Small-Cell Lung28
Adenocarcinoma23
Lung Neoplasms17
Head and Neck Neoplasms16
Breast Neoplasms15
Squamous Cell Carcinoma of Head and Neck15
Pancreatic Neoplasms14

Trials

Showing 1 to 25 of 205. Each trial links to its page on Pharma Observatory.

105 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.